Current options to manage Waldenström’s macroglobulinemia
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2017.1339596
Abstract: ABSTRACT Introduction: Waldenström’s macroglobulinemia (WM) is a rare, incurable B-cell lymphoma, with a median survival of 5–10 years in symptomatic patients. There is no consensus on the standard of care and several agents are currently… read more here.
Keywords: current options; waldenstr macroglobulinemia; manage waldenstr; macroglobulinemia ... See more keywords